275 related articles for article (PubMed ID: 31250383)
1. Early Sociability and Social Memory Impairment in the A53T Mouse Model of Parkinson's Disease Are Ameliorated by Chemogenetic Modulation of Orexin Neuron Activity.
Stanojlovic M; Pallais Yllescas JP; Vijayakumar A; Kotz C
Mol Neurobiol; 2019 Dec; 56(12):8435-8450. PubMed ID: 31250383
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson's disease.
Stanojlovic M; Pallais JP; Lee MK; Kotz CM
Mol Brain; 2019 Oct; 12(1):87. PubMed ID: 31666100
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Orexin/Hypocretin Neurons Ameliorates Elevated Physical Activity and Energy Expenditure in the A53T Mouse Model of Parkinson's Disease.
Stanojlovic M; Pallais JP; Kotz CM
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466831
[TBL] [Abstract][Full Text] [Related]
4. Chemogenetic Modulation of Orexin Neurons Reverses Changes in Anxiety and Locomotor Activity in the A53T Mouse Model of Parkinson's Disease.
Stanojlovic M; Pallais JP; Kotz CM
Front Neurosci; 2019; 13():702. PubMed ID: 31417337
[TBL] [Abstract][Full Text] [Related]
5. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease.
Paumier KL; Sukoff Rizzo SJ; Berger Z; Chen Y; Gonzales C; Kaftan E; Li L; Lotarski S; Monaghan M; Shen W; Stolyar P; Vasilyev D; Zaleska M; D Hirst W; Dunlop J
PLoS One; 2013; 8(8):e70274. PubMed ID: 23936403
[TBL] [Abstract][Full Text] [Related]
6. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
[TBL] [Abstract][Full Text] [Related]
7. Orexin signaling during social defeat stress influences subsequent social interaction behaviour and recognition memory.
Eacret D; Grafe LA; Dobkin J; Gotter AL; Renger JJ; Winrow CJ; Bhatnagar S
Behav Brain Res; 2019 Jan; 356():444-452. PubMed ID: 29902478
[TBL] [Abstract][Full Text] [Related]
8. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
[TBL] [Abstract][Full Text] [Related]
9. NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's Disease.
Sirabella R; Sisalli MJ; Costa G; Omura K; Ianniello G; Pinna A; Morelli M; Di Renzo GM; Annunziato L; Scorziello A
Cell Death Dis; 2018 Jun; 9(7):725. PubMed ID: 29941946
[TBL] [Abstract][Full Text] [Related]
10. Chemogenetic activation of orexin/hypocretin neurons ameliorates aging-induced changes in behavior and energy expenditure.
Stanojlovic M; Pallais Yllescas JP; Mavanji V; Kotz C
Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R571-R583. PubMed ID: 30726119
[TBL] [Abstract][Full Text] [Related]
11. Orexin pathway in Parkinson's disease: a review.
Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Zaafar D; Batiha GE
Mol Biol Rep; 2023 Jul; 50(7):6107-6120. PubMed ID: 37155018
[TBL] [Abstract][Full Text] [Related]
12. Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential.
Liu C; Xue Y; Liu MF; Wang Y; Chen L
Neurochem Int; 2020 Sep; 138():104754. PubMed ID: 32422324
[TBL] [Abstract][Full Text] [Related]
13. Activation of orexin system facilitates anesthesia emergence and pain control.
Zhou W; Cheung K; Kyu S; Wang L; Guan Z; Kurien PA; Bickler PE; Jan LY
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10740-E10747. PubMed ID: 30348769
[TBL] [Abstract][Full Text] [Related]
14. Repeated Activation of Pyramidal Neurons in the Prefrontal Cortex Alters Microglial Phenotype in Male Mice.
Bollinger JL; Horchar MJ; Wohleb ES
J Pharmacol Exp Ther; 2024 Jan; 388(2):715-723. PubMed ID: 38129124
[TBL] [Abstract][Full Text] [Related]
15. Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet.
Bunney PE; Zink AN; Holm AA; Billington CJ; Kotz CM
Physiol Behav; 2017 Jul; 176():139-148. PubMed ID: 28363838
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Role of Orexinergic Neurons in Parkinson's Disease.
Kumar S; Behl T; Sehgal A; Singh S; Sharma N; Bhatia S; Al-Harassi A; Abdel-Daim MM; Bungau S
Neurotox Res; 2021 Dec; 39(6):2141-2153. PubMed ID: 34495449
[TBL] [Abstract][Full Text] [Related]
18. Medial Prefrontal Cortex Neural Plasticity, Orexin Receptor 1 Signaling, and Connectivity with the Lateral Hypothalamus Are Necessary in Cue-Potentiated Feeding.
Cole S; Keefer SE; Anderson LC; Petrovich GD
J Neurosci; 2020 Feb; 40(8):1744-1755. PubMed ID: 31953368
[TBL] [Abstract][Full Text] [Related]
19. Optogenetic Stimulation of the M2 Cortex Reverts Motor Dysfunction in a Mouse Model of Parkinson's Disease.
Magno LAV; Tenza-Ferrer H; Collodetti M; Aguiar MFG; Rodrigues APC; da Silva RS; Silva JDP; Nicolau NF; Rosa DVF; Birbrair A; Miranda DM; Romano-Silva MA
J Neurosci; 2019 Apr; 39(17):3234-3248. PubMed ID: 30782975
[TBL] [Abstract][Full Text] [Related]
20. Conditional neuroligin-2 knockout in adult medial prefrontal cortex links chronic changes in synaptic inhibition to cognitive impairments.
Liang J; Xu W; Hsu YT; Yee AX; Chen L; Südhof TC
Mol Psychiatry; 2015 Jul; 20(7):850-9. PubMed ID: 25824299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
